Billions in funding for AeroVax: Inhalable mRNA vaccine aims to overcome needle fear – critics warn of secret administration
Scientists are working on a new AeroVax covid mRNA vaccine that aims to overcome public reservations about conventional vaccinations through needle-free administration. Instead of an injection, the vaccine is inhaled.
Researchers at McMaster University in Canada, funded by the Bill & Melinda Gates Foundation, have launched a Phase 2 clinical trial for the inhaled covid vaccine. The vaccine is atomized into a fine mist and absorbed through the respiratory tract.
The developers are touting AeroVax as a potential breakthrough in protection against respiratory viruses. The clinical trial recently received $8 million in government funding from the Canadian Institutes of Health Research (CIHR). The goal is to test the vaccine’s safety and immune response.
Study program and objectives
The trial will involve 350 participants in Hamilton, Ottawa, and Halifax. The vaccine was developed at the Robert E. Fitzhenry Vector Laboratory under the direction of Dr. Fiona Smaill and Dr. Zhou Xing. It builds on Phase 1 data claiming that inhaled administration of this new mRNA “vaccine” may elicit stronger immune responses than injections because it directly targets the lungs and upper respiratory tract —the exact site where SARS-CoV-2 enters the body.
Researchers say AeroVax will help governments vaccinate more people by overcoming reservations about needle injections.
Study design and eligibility criteria
Two-thirds of participants will receive AeroVax and one-third will receive a placebo to objectively compare immunity levels and side effects.
Conditions for participation: at least three previous mRNA vaccinations, no AstraZeneca vaccination, no recent infection.
Age: 18 to 65 years, no diagnosed lung diseases.
The study marks a crucial step toward Phase 3 testing, which will evaluate efficacy in a larger population. Following a successful Phase 3 trial, AeroVax could receive regulatory approval for public use.
Concerns about potential misuse
Concerns are growing that AeroVax could be misused. Critics warn that the inhalable vaccine could easily be sprayed into the atmosphere and “vaccinate” people without their knowledge or consent.
Rising death toll after mRNA booster
The development of AeroVax comes after Canada recently acknowledged an alarming increase in deaths among vaccinated people. As Slay News reports, the Canadian government confirmed that mRNA boosters correlate with a sharp increase in mortality.
A report by the Public Health Agency of Canada (PHAC) shows that people who received a third or fourth mRNA vaccination have a significantly higher mortality rate than unvaccinated people.
The new revelations about the health consequences of mRNA injections raise serious questions – and reinforce fears that AeroVax could soon be used forcibly or unchecked.
yogaesoteric
March 20, 2025
